regulation-consultancy

UTT BioPharma is contributing to political and law reform reviews in Australia and Italy, aiming to create a medicinal cannabis scheme to allow patients access to products that may have a great impact on their quality of life. Advice can be provided in any areas of interest including:

  • The regulatory pathway concerning research into cannabis-derived substances, and strategies to develop reform in their respective political syndicates.
  • Professional legal advice from highly distinguished lawyers could be accessed through UTT BioPharma, to make sure that any reform efforts are made in full compliance with local legislation.
  • Developing and setting up models and schemes to ease access to cannabis-derived therapeutics within full compliance of the 1961 United Nations (UN) Single Convention on Narcotic Drugs, the 1971 UN Convention on Psychotropic Substances and 1988 UN convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.